ACU-D2

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameACU-D2
Drug Alias NameACU-D2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNAD-dependent protein deacetylase sirtuin-3, mitochondrial agonists
TargetsNAD-dependent protein deacetylase sirtuin-3, mitochondrial
Therapy Area/IndicationsScleroderma, SystemicAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAccuitis Inc
China Registration ClassN/A

Develop Information

Active CompaniesAccuitis Inc
Inactive CompaniesN/A
Active IndicationsScleroderma, SystemicAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A